Mark Kendell: Ledger

Stories naming Mark Kendell. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Role	Organisation	Sources
Professor	University of Queensland	labonline.com.au

Unnamed stage $15m

Vaxxas gets $15m injection to develop needle-free vaccine

Biotech startup Vaxxas has raised $15 million in venture capital, led by OneVentures with Brandon Capital, MRCF and HealthCare Ventures, to commercialise the Nanopatch needle-free vaccine delivery technology developed at Queensland university institute AIBN.

labonline.com.au Tue 2 Aug 2011 Vaxxas University of Queensland Brandon Capital Healthcare Ventures Medical Research Commercialisation Fund (MRCF)OneVentures Mark Kendell Dr Paul Kelly

Also Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·SmartCompany·SmartCompany·labonline.com.au

Mark Kendell

Roles

Coverage

Vaxxas gets $15m injection to develop needle-free vaccine